VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics.

[1]  Dai Fukumura,et al.  Impaired lymphatic contraction associated with immunosuppression , 2011, Proceedings of the National Academy of Sciences.

[2]  Kutlu G. Elpek,et al.  Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes , 2011, Nature Immunology.

[3]  Pedro Romero,et al.  Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients. , 2011, The Journal of clinical investigation.

[4]  D. Steinhilber,et al.  Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. , 2011, The Journal of clinical investigation.

[5]  Matthew J. Paszek,et al.  Balancing forces: architectural control of mechanotransduction , 2011, Nature Reviews Molecular Cell Biology.

[6]  D. Lyden,et al.  The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. , 2011, Seminars in cancer biology.

[7]  Melody A Swartz,et al.  Tumor cell invasion is promoted by interstitial flow-induced matrix priming by stromal fibroblasts. , 2011, Cancer research.

[8]  G. Koh,et al.  T lymphocytes negatively regulate lymph node lymphatic vessel formation. , 2011, Immunity.

[9]  Kutlu G. Elpek,et al.  The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs , 2010, Nature Reviews Immunology.

[10]  J. Hubbell,et al.  Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation. , 2010, Vaccine.

[11]  M. Swartz,et al.  Role of Lymphatic Vessels in Tumor Immunity: Passive Conduits or Active Participants? , 2010, Journal of Mammary Gland Biology and Neoplasia.

[12]  V. Engelhard,et al.  Tumor masses support naive T cell infiltration, activation, and differentiation into effectors , 2010, The Journal of experimental medicine.

[13]  R. Écochard,et al.  Chronic Rejection Triggers the Development of an Aggressive Intragraft Immune Response through Recapitulation of Lymphoid Organogenesis , 2010, The Journal of Immunology.

[14]  Melody A. Swartz,et al.  Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21 , 2010, Science.

[15]  H. Schild,et al.  Dynamic Regulation of CD8 T Cell Tolerance Induction by Liver Sinusoidal Endothelial Cells , 2010, The Journal of Immunology.

[16]  A. Ruddell,et al.  Lymph node–resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation , 2010, The Journal of experimental medicine.

[17]  L. Santambrogio,et al.  An Expanded Self-Antigen Peptidome Is Carried by the Human Lymph As Compared to the Plasma , 2010, PloS one.

[18]  Melody A. Swartz,et al.  Transmural Flow Modulates Cell and Fluid Transport Functions of Lymphatic Endothelium , 2010, Circulation research.

[19]  K. Alitalo,et al.  Lymphangiogenesis: Molecular Mechanisms and Future Promise , 2010, Cell.

[20]  R. Weiskirchen,et al.  Systemic antigen cross‐presented by liver sinusoidal endothelial cells induces liver‐specific CD8 T‐cell retention and tolerization , 2009, Hepatology.

[21]  Antal Rot,et al.  CCR7 and its ligands: balancing immunity and tolerance , 2008, Nature Reviews Immunology.

[22]  V. Engelhard,et al.  Strategies and challenges in eliciting immunity to melanoma , 2008, Immunological reviews.

[23]  B. Hinz,et al.  Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells , 2007, Nature Immunology.

[24]  Melody A Swartz,et al.  Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. , 2007, Cancer cell.

[25]  A. Ruddell,et al.  Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. , 2007, The American journal of pathology.

[26]  D. Munn,et al.  The tumor‐draining lymph node as an immune‐privileged site , 2006, Immunological reviews.

[27]  Melody A Swartz,et al.  Autologous morphogen gradients by subtle interstitial flow and matrix interactions. , 2006, Biophysical journal.

[28]  M. Skobe,et al.  Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. , 2006, Cancer research.

[29]  R. Hynes,et al.  Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. , 2005, Cancer research.

[30]  Melody A. Swartz,et al.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels , 2005, Nature Reviews Immunology.

[31]  A. Anichini,et al.  The paradox of T cell–mediated antitumor immunity in spite of poor clinical outcome in human melanoma , 2004, Cancer Immunology, Immunotherapy.

[32]  A. Mackensen,et al.  Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. , 2004, Cancer research.

[33]  K. Alitalo,et al.  Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. , 2002, Journal of the National Cancer Institute.

[34]  Rakesh K Jain,et al.  Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.

[35]  T. Furuhata,et al.  Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice. , 2001, Journal of experimental & clinical cancer research : CR.

[36]  L. Orci,et al.  Vascular endothelial growth factor‐C‐mediated lymphangiogenesis promotes tumour metastasis , 2001, The EMBO journal.

[37]  Thomas Hawighorst,et al.  Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.

[38]  L. Santambrogio,et al.  The lymph as a pool of self-antigens. , 2011, Trends in immunology.

[39]  O. Colegio,et al.  Lymphangiogenesis linked to VEGF-C from tumor-associated macrophages: accomplices to metastasis by cutaneous squamous cell carcinoma? , 2011, The Journal of investigative dermatology.

[40]  M. Swartz,et al.  Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. , 2009, Cancer research.

[41]  S. Turley,et al.  Peripheral tolerance induction by lymph node stroma. , 2009, Advances in experimental medicine and biology.

[42]  Michael Sixt,et al.  The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. , 2005, Immunity.

[43]  M. H. Friedlaender,et al.  Immunologic tolerance: role of the regional lymph node. , 1972, Science.